Xynomic Pharmaceuticals Holdings, Inc. is a blank check company incorporated and registered with the SEC under CIK 0001697805, operating within the pharmaceutical and healthcare sector. The company filed a Form 10-Q with the SEC on August 11, 2017, reflecting quarterly reporting obligations consistent with an active SPAC structure during that period. Focused on identifying and completing a business combination with a target in the life sciences and pharmaceutical space, Xynomic represents the class of healthcare-oriented SPACs that gained traction during the mid-2010s wave of blank check activity. Sponsor details are not confirmed in available public disclosures. For full filing history, deal status, and sponsor data on Xynomic and thousands of other SPACs, sign up for complete access at SpacDesk.